Correlation Between Coya Therapeutics, and In8bio

Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coya Therapeutics, Common and In8bio Inc, you can compare the effects of market volatilities on Coya Therapeutics, and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and In8bio.

Diversification Opportunities for Coya Therapeutics, and In8bio

0.15

Correlation Coefficient

Coya Therapeutics,  In8bio

Average diversification

The 3 months correlation between Coya and In8bio is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and In8bio go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and In8bio

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the In8bio. But the stock apears to be less risky and, when comparing its historical volatility, Coya Therapeutics, Common is 2.11 times less risky than In8bio. The stock trades about 0.0 of its potential returns per unit of risk. The In8bio Inc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  26.00  in In8bio Inc on October 1, 2024 and sell it today you would earn a total of  1.00  from holding In8bio Inc or generate 3.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Coya Therapeutics, Common  vs.  In8bio Inc

Coya Therapeutics, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

In8bio Inc

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in In8bio Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, In8bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Coya Therapeutics, and In8bio

The main advantage of trading using opposite Coya Therapeutics, and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.

The idea behind Coya Therapeutics, Common and In8bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.